100 related articles for article (PubMed ID: 9143397)
21. The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.
Hassen E; Nahla G; Bouaouina N; Chouchane L
Mol Biol Rep; 2010 Jan; 37(1):119-26. PubMed ID: 19449168
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma.
Hsu WL; Tse KP; Liang S; Chien YC; Su WH; Yu KJ; Cheng YJ; Tsang NM; Hsu MM; Chang KP; Chen IH; Chen TI; Yang CS; Goldstein AM; Chen CJ; Chang YS; Hildesheim A
PLoS One; 2012; 7(8):e42767. PubMed ID: 22880099
[TBL] [Abstract][Full Text] [Related]
23. Nasopharyngeal carcinoma as a paradigm of cancer genetics.
Simons MJ
Chin J Cancer; 2011 Feb; 30(2):79-84. PubMed ID: 21272439
[TBL] [Abstract][Full Text] [Related]
24. Serological analysis of human leukocyte antigens-A and -B antigens in Thai patients with nasopharyngeal carcinoma.
Pimtanothai N; Kangwanshiratada O; Charoenwongse P
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S237-41. PubMed ID: 12929995
[TBL] [Abstract][Full Text] [Related]
25. Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility.
Wang TM; Zhou T; He YQ; Xue WQ; Zhang JB; Zheng XH; Li XZ; Zhang SD; Zeng YX; Jia WH
Cancer Med; 2018 Dec; 7(12):6308-6316. PubMed ID: 30378292
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin allotypes in patients with nasopharyngeal carcinoma.
Chaabani H; Ellouz R
Hum Hered; 1986; 36(6):402-4. PubMed ID: 3793120
[TBL] [Abstract][Full Text] [Related]
27. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States.
Burt RD; Vaughan TL; McKnight B; Davis S; Beckmann AM; Smith AG; Nisperos B; Swanson GM; Berwick M
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):879-87. PubMed ID: 8922295
[TBL] [Abstract][Full Text] [Related]
28. Association between nasopharyngeal carcinoma and HLA antigens in Greeks.
Zervas J; Gregoriadis S; Tourlas D; Varlegidis E; Pantazopoulos P
Panminerva Med; 1983; 25(4):255-7. PubMed ID: 6584851
[No Abstract] [Full Text] [Related]
29. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese.
Lu CC; Chen JC; Jin YT; Yang HB; Chan SH; Tsai ST
Int J Cancer; 2003 Mar; 103(6):745-51. PubMed ID: 12516093
[TBL] [Abstract][Full Text] [Related]
30. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
31. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand.
Pimtanothai N; Charoenwongse P; Mutirangura A; Hurley CK
Tissue Antigens; 2002 Mar; 59(3):223-5. PubMed ID: 12074714
[TBL] [Abstract][Full Text] [Related]
32. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2).
Simons MJ; Wee GB; Goh EH; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
J Natl Cancer Inst; 1976 Nov; 57(5):977-80. PubMed ID: 1003552
[TBL] [Abstract][Full Text] [Related]
33. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
[TBL] [Abstract][Full Text] [Related]
34. Immunogenetics of nasopharyngeal carcinoma--position in 1980.
Chan SH
Ann Acad Med Singap; 1980 Jul; 9(3):296-9. PubMed ID: 7212610
[TBL] [Abstract][Full Text] [Related]
35. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma.
Simons MJ; Day NE
Natl Cancer Inst Monogr; 1977 Dec; 47():143-6. PubMed ID: 613232
[TBL] [Abstract][Full Text] [Related]
36. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
[TBL] [Abstract][Full Text] [Related]
37. [Immunogenetics of nasopharyngeal carcinoma].
Chaaben AB; Abaza H; Douik H; Harzallah L; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
Ann Biol Clin (Paris); 2014; 72(3):281-91. PubMed ID: 24876139
[TBL] [Abstract][Full Text] [Related]
38. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.
Goldsmith DB; West TM; Morton R
Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):61-7. PubMed ID: 11903375
[TBL] [Abstract][Full Text] [Related]
39. Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
Romero V; Larsen CE; Duke-Cohan JS; Fox EA; Romero T; Clavijo OP; Fici DA; Husain Z; Almeciga I; Alford DR; Awdeh ZL; Zuñiga J; El-Dahdah L; Alper CA; Yunis EJ
BMC Genet; 2007 Apr; 8():14. PubMed ID: 17430593
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.
Khanna R; Busson P; Burrows SR; Raffoux C; Moss DJ; Nicholls JM; Cooper L
Cancer Res; 1998 Jan; 58(2):310-4. PubMed ID: 9443410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
